Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Revenue
Annual & quarterly revenue history · segment & region breakdown
LMRI · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsLumexa Imaging Holdings, Inc. Common Stock trailing twelve-month (TTM) revenue is $0.77B, an increase of 7.82% year-over-year from $1.02B in FY2025.
Revenue trend
2025 – 2023 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.02B | +$0.07B | +7.82% |
| 2024-12-31 | $0.95B | +$0.01B | +1.38% |
| 2023-12-31 | $0.94B | — | — |
Compare revenue vs peers
Medical - DevicesCompare LMRI revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Lumexa Imaging Holdings, Inc. Common Stock receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Lumexa Imaging Holdings, Inc. Common Stock reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Lumexa Imaging Holdings, Inc. Common Stock's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LMRI revenue · 4 questionsLMRI's trailing twelve-month (TTM) revenue is $0.77B. That is an increase of 7.82% year-over-year from $1.02B in FY2025.
▸ Source: FMP · Lumexa Imaging Holdings, Inc. Common Stock SEC filings · GAAP · Lumexa Imaging Holdings, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026